Critical Aspects of Initiation, Promotion, and Progression in Multistage Epidermal Carcinogenesis

Abstract Carcinogenesis in mouse skin can be divided into three distinct stages: initiation, promotion, and progression (malignant conversion). Initiation, induced by a single exposure to a genotoxic carcinogen, can result from a mutation in a single critical gene (e.g., rasHa), apparently in only a few epidermal cells. The change is irreversible. Promotion, resulting in the development of numerous benign tumors (papillomas), is accomplished by the repeated application of a nonmutagenic tumor promoter. The effects of single applications of tumor promoters are reversible since papillomas do not develop after insufficient exposure of initiated skin to promoters or when the interval between individual promoter applications is increased sufficiently. The reversibility of promotion suggests an epigenetic mechanism. Promoter treatment provides an environment that allows the selective clonal expansion of foci of initiated cells. The conversion of squamous papillomas to carcinomas (termed progression or malignant conversion) occurs spontaneously at a low frequency. The rate of progression to malignancy can be significantly increased by treatment of papilloma-bearing mice with certain genotoxic agents. These progressor agents or converting agents are likely to act via a second genetic change in papillonias already bearing the initiating mutation. Progression in the skin is characterized by genetic changes that result in several distinct changes in the levels or activity of structural proteins, growth factors, and proteases. The mechanisms involved in progression are being studied in epidermal cell culture. In order to determine the in vivo phenotype of cultured cells, a grafting system was developed in which the cells were transferred from culture to a prepared skin bed in athymic mice. Introduction of an activated v-fos oncogene into initiated cells bearing an activated ras Ha gene produced cells with a carcinoma phenotype, of Initiation i.e., carcinomas formed when the cells were grafted as part of reconstituted skin. Grafted keratinocytes containing the ras Ha gene alone produced papillomas; with v-fos alone, normal skin formed when grafted. The ras Ha/fos carcinomas showed changes in differentiation markers characteristic of chemically induced carcinomas. A cell culture assay utilizing cells initiated by the introduction of an activated ras Ha oncogene was developed to study progression. After exposure of initiated cells to progressor agents under conditions in which the proliferation of the ras Ha-initiated cells was suppressed, proliferating foci developed, with a good correlation of activity in the assay with activity in the progression stage in vivo. The cell culture assay provides a quantitative model to study chemically induced neoplastic progression and may be useful to identify potential progressor agents.

[1]  T. Slaga,et al.  Simultaneous appearance of keratin modifications and gamma-glutamyltransferase activity as indicators of tumor progression in mouse skin papillomas. , 1983, Journal of the National Cancer Institute.

[2]  R. Tarone,et al.  Enhanced malignant conversion of benign mouse skin tumors by cisplatin. , 1990, Journal of the National Cancer Institute.

[3]  I. Verma,et al.  The fos oncogene. , 1987, Advances in cancer research.

[4]  I. Berenblum,et al.  The Persistence of Latent Tumour Cells Induced in the Mouse's Skin by a Single Application of 9:10-Dimethyl-1:2-Benzanthracene , 1949, British Journal of Cancer.

[5]  E. Scolnick,et al.  Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals. , 1983, Cancer research.

[6]  A. Balmain,et al.  v-ras genes from harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis , 1986, Cell.

[7]  S. Yuspa,et al.  Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene , 1988, Molecular carcinogenesis.

[8]  V. Potter A new protocol and its rationale for the study of initiation and promotion of carcinogenesis in rat liver. , 1981, Carcinogenesis.

[9]  M. Sporn,et al.  Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras. , 1991, Molecular Carcinogenesis.

[10]  S. Yuspa,et al.  Malignant conversion and metastasis of mouse skin tumors: a comparison of SENCAR and CD-1 mice. , 1986, Environmental health perspectives.

[11]  R. Tarone,et al.  Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters , 1983, Nature.

[12]  S H Moolgavkar,et al.  Mutation and cancer: a model for human carcinogenesis. , 1981, Journal of the National Cancer Institute.

[13]  C. Conti,et al.  Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice. , 1987, Cancer research.

[14]  H. T. Deelman THE PART PLAYED BY INJURY AND REPAIR IN THE DEVELOPMENT OF CANCER , 1927, British medical journal.

[15]  S. Yuspa Cellular and molecular changes during chemical carcinogenesis in mouse skin cells. , 1985, Carcinogenesis; a comprehensive survey.

[16]  T. Slaga,et al.  Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[18]  A. Steven,et al.  Identification of a major keratinocyte cell envelope protein, loricrin , 1990, Cell.

[19]  I. Berenblum,et al.  The Mechanism of Carcinogenesis. A Study of the Significance of Cocarcinogenic Action and Related Phenomena , 1941 .

[20]  S. Yuspa,et al.  Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Slaga,et al.  Malignant progression of mouse skin papillomas treated with ethylnitrosourea, N-methyl-N'-nitro-N-nitrosoguanidine, or 12-O-tetradecanoylphorbol-13-acetate. , 1986, Cancer letters.

[22]  J. Mottram A developing factor in experimental blastogenesis , 1944 .

[23]  V. Castronovo,et al.  Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. , 1992, Cancer research.

[24]  A. Balmain,et al.  Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Robert A. Weinberg,et al.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.

[26]  J. Williamson,et al.  Ionizing radiation enhances malignant progression of mouse skin tumors. , 1987, Carcinogenesis.

[27]  H. Hennings,et al.  Enhancement of skin tumorigenesis by a single application of croton oil before or soon after initiation by urethan. , 1973, Cancer research.

[28]  Allan Balmain,et al.  Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas , 1984, Nature.

[29]  P. Shubik The growth potentialities of induced skin tumors in mice; the effects of different methods of chemical carcinogenesis. , 1950, Cancer research.

[30]  D. Roop,et al.  Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. , 1988, Cancer research.

[31]  T. Slaga,et al.  Enhanced malignant progression of mouse skin tumors by the free-radical generator benzoyl peroxide. , 1986, Cancer research.

[32]  H. Hennings,et al.  Studies on the mechanism of skin tumor promotion. , 1970, Cancer research.

[33]  P. Shubik,et al.  A New, Quantitative, Approach to the Study of the Stages of Chemical Carcinogenesis in the Mouse's Skin , 1947, British Journal of Cancer.

[34]  S. Yuspa,et al.  Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells. , 1992, Cancer research.

[35]  S. Yuspa,et al.  Induction of papillomas with a high probability of conversion to malignancy. , 1985, Carcinogenesis.

[36]  Potter Vr Initiation and promotion in cancer formation: the importance of studies on intercellular communication. , 1980 .

[37]  I. Verma,et al.  Differential expression of cellular oncogenes during pre- and postnatal development of the mouse , 1982, Nature.

[38]  E. Lane,et al.  Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia. , 1991, The Journal of investigative dermatology.

[39]  R. Storer,et al.  Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene. , 1986, Cancer research.

[40]  R. Roberts,et al.  Activation of the cellular harvey ras gene in mouse skin tumors initiated with urethane , 1989, Molecular carcinogenesis.

[41]  S. Yuspa,et al.  Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. , 1988, Cancer research.

[42]  S. Yuspa,et al.  Response of carcinogen-altered mouse epidermal cells to phorbol ester tumor promoters and calcium. , 1987, The Journal of investigative dermatology.

[43]  S. Yuspa,et al.  Sensitivity of subpopulations of mouse skin papillomas to malignant conversion by urethane or 4-nitroquinoline N-oxide. , 1990, Cancer research.

[44]  L. Matrisian,et al.  The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Lowy,et al.  An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue , 1986, Nature.

[46]  D. Roop,et al.  Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis. , 1991, Environmental health perspectives.

[47]  T. Slaga,et al.  Mechanisms of inhibition of tumor progression. , 1993, Basic life sciences.